CD5 and neoplasm: Contrary to the general idea that Bregs have a pro-tumour effect, it has been shown that the frequency of Bregs (CD5+, CD1dhiCD5+, and CD24hiCD38hi) decreased as tumours progressed from early to late stages, and that the frequency of Bregs in TDLN was positively associated with good prognostic clinical parameters [116].